CHEK1 and lymphoma: Total and phospho proteomic analysis revealed that Eμ-Myc/cRel−/− lymphomas highly resemble wild-type (WT) Eμ-Myc lymphomas treated with an acute dose of the CHK1 inhibitor (CHK1i) CCT244747.